These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 18097590
1. Loss of ONECUT1 expression in human pancreatic cancer cells. Jiang X, Zhang W, Kayed H, Zheng P, Giese NA, Friess H, Kleeff J. Oncol Rep; 2008 Jan; 19(1):157-63. PubMed ID: 18097590 [Abstract] [Full Text] [Related]
2. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis. Kayed H, Kleeff J, Keleg S, Felix K, Giese T, Berger MR, Büchler MW, Friess H. Cancer Lett; 2007 Jan 08; 245(1-2):171-83. PubMed ID: 16488077 [Abstract] [Full Text] [Related]
3. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas. Kayed H, Kleeff J, Esposito I, Giese T, Keleg S, Giese N, Büchler MW, Friess H. Mol Carcinog; 2005 Apr 08; 42(4):183-92. PubMed ID: 15754313 [Abstract] [Full Text] [Related]
4. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma. Wente MN, Gaida MM, Mayer C, Michalski CW, Haag N, Giese T, Felix K, Bergmann F, Giese NA, Friess H. Int J Oncol; 2008 Aug 08; 33(2):297-308. PubMed ID: 18636150 [Abstract] [Full Text] [Related]
5. Expression analysis of PMP22/Gas3 in premalignant and malignant pancreatic lesions. Li J, Kleeff J, Esposito I, Kayed H, Felix K, Giese T, Büchler MW, Friess H. J Histochem Cytochem; 2005 Jul 08; 53(7):885-93. PubMed ID: 15995147 [Abstract] [Full Text] [Related]
6. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Guweidhi A, Kleeff J, Giese N, El Fitori J, Ketterer K, Giese T, Büchler MW, Korc M, Friess H. Carcinogenesis; 2004 Sep 08; 25(9):1575-85. PubMed ID: 15073049 [Abstract] [Full Text] [Related]
7. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion. Kayed H, Bekasi S, Keleg S, Michalski CW, Giese T, Friess H, Kleeff J. Mol Cancer; 2007 Dec 28; 6():83. PubMed ID: 18163903 [Abstract] [Full Text] [Related]
8. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis. Ohuchida K, Mizumoto K, Miyasaka Y, Yu J, Cui L, Yamaguchi H, Toma H, Takahata S, Sato N, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M. J Pathol; 2007 Nov 28; 213(3):275-82. PubMed ID: 17940995 [Abstract] [Full Text] [Related]
9. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer. Zhang ML, Lu S, Zhou L, Zheng SS. Hepatobiliary Pancreat Dis Int; 2008 Oct 28; 7(5):533-8. PubMed ID: 18842503 [Abstract] [Full Text] [Related]
10. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. Esposito I, Penzel R, Chaib-Harrireche M, Barcena U, Bergmann F, Riedl S, Kayed H, Giese N, Kleeff J, Friess H, Schirmacher P. J Pathol; 2006 Apr 28; 208(5):673-85. PubMed ID: 16450333 [Abstract] [Full Text] [Related]
12. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer. Baker AF, Koh MY, Williams RR, James B, Wang H, Tate WR, Gallegos A, Von Hoff DD, Han H, Powis G. Pancreas; 2008 Mar 28; 36(2):178-86. PubMed ID: 18376310 [Abstract] [Full Text] [Related]
13. Targeting of suicide gene delivery in pancreatic cancer cells via FGF receptors. Kleeff J, Fukahi K, Lopez ME, Friess H, Büchler MW, Sosnowski BA, Korc M. Cancer Gene Ther; 2002 Jun 28; 9(6):522-32. PubMed ID: 12032663 [Abstract] [Full Text] [Related]
14. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma. Xue A, Scarlett CJ, Jackson CJ, Allen BJ, Smith RC. Pancreas; 2008 Mar 28; 36(2):160-7. PubMed ID: 18376307 [Abstract] [Full Text] [Related]
15. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. Takehara A, Hosokawa M, Eguchi H, Ohigashi H, Ishikawa O, Nakamura Y, Nakagawa H. Cancer Res; 2007 Oct 15; 67(20):9704-12. PubMed ID: 17942900 [Abstract] [Full Text] [Related]
16. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Motoda N, Matsuda Y, Onda M, Ishiwata T, Uchida E, Naito Z. Int J Oncol; 2011 Jan 15; 38(1):133-43. PubMed ID: 21109934 [Abstract] [Full Text] [Related]
17. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J. Ann Surg Oncol; 2009 Aug 15; 16(8):2339-50. PubMed ID: 19475450 [Abstract] [Full Text] [Related]
18. The effect of aberrant maspin expression on the invasive ability of pancreatic ductal adenocarcinoma cells. Hong SN, Lee JK, Choe WH, Ha HY, Park K, Sung IK, Lee KT, Kim JJ, Rhee JC. Oncol Rep; 2009 Feb 15; 21(2):425-30. PubMed ID: 19148518 [Abstract] [Full Text] [Related]
19. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer. Koide N, Yamada T, Shibata R, Mori T, Fukuma M, Yamazaki K, Aiura K, Shimazu M, Hirohashi S, Nimura Y, Sakamoto M. Clin Cancer Res; 2006 Apr 15; 12(8):2419-26. PubMed ID: 16638847 [Abstract] [Full Text] [Related]
20. Protease-activated receptor-2 regulates cell proliferation and enhances cyclooxygenase-2 mRNA expression in human pancreatic cancer cells. Yada K, Shibata K, Matsumoto T, Ohta M, Yokoyama S, Kitano S. J Surg Oncol; 2005 Feb 01; 89(2):79-85. PubMed ID: 15660373 [Abstract] [Full Text] [Related] Page: [Next] [New Search]